Shengjun Wang

Array ( [id] => 10534756 [patent_doc_number] => 09260375 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-16 [patent_title] => 'Metallo-β-lactamase inhibitors' [patent_app_type] => utility [patent_app_number] => 13/306372 [patent_app_country] => US [patent_app_date] => 2011-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30806 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13306372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8828635 [patent_doc_number] => 20130129680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-23 [patent_title] => 'METHOD FOR TREATING HEPATITIS C VIRUS INFECTION USING QUERCETIN-CONTAINING COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/303467 [patent_app_country] => US [patent_app_date] => 2011-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2699 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13303467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8043511 [patent_doc_number] => 20120071495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'Treatment for Neurological and Mental Disorders' [patent_app_type] => utility [patent_app_number] => 13/303210 [patent_app_country] => US [patent_app_date] => 2011-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16465 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 38 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20120071495.pdf [firstpage_image] =>[orig_patent_app_number] => 13303210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10095834 [patent_doc_number] => 09132129 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-15 [patent_title] => 'Antiviral compounds' [patent_app_type] => utility [patent_app_number] => 13/885526 [patent_app_country] => US [patent_app_date] => 2011-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36461 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13885526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8417687 [patent_doc_number] => 20120245188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'METHODS OF TREATING MEMORY LOSS AND ENHANCING MEMORY PERFORMANCE' [patent_app_type] => utility [patent_app_number] => 13/297149 [patent_app_country] => US [patent_app_date] => 2011-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5927 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13297149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7784682 [patent_doc_number] => 20120046238 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'COUMARIN COMPOUNDS AND THEIR USE FOR TREATING VIRAL INFECTION' [patent_app_type] => utility [patent_app_number] => 13/293181 [patent_app_country] => US [patent_app_date] => 2011-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28775 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20120046238.pdf [firstpage_image] =>[orig_patent_app_number] => 13293181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8186857 [patent_doc_number] => 20120115903 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'Substituted Heteroaromatic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands' [patent_app_type] => utility [patent_app_number] => 13/292785 [patent_app_country] => US [patent_app_date] => 2011-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36980 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20120115903.pdf [firstpage_image] =>[orig_patent_app_number] => 13292785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14594027 [patent_doc_number] => 10350188 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-07-16 [patent_title] => Use of Neu1 sialidase inhibitors in the treatment of cancer [patent_app_type] => utility [patent_app_number] => 14/370916 [patent_app_country] => US [patent_app_date] => 2011-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 19653 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14370916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8173776 [patent_doc_number] => 20120108592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF SALICYLANILIDES FOR TREATMENT OF HEPATITIS VIRUSES' [patent_app_type] => utility [patent_app_number] => 13/284232 [patent_app_country] => US [patent_app_date] => 2011-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21171 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20120108592.pdf [firstpage_image] =>[orig_patent_app_number] => 13284232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8264793 [patent_doc_number] => 20120164221 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'COMBINATIONS OF HMG-COA REDUCTASE INHIBITORS AND NICOTINIC ACID COMPOUNDS AND METHODS FOR TREATING HYPERLIPIDEMIA ONCE A DAY AT NIGHT' [patent_app_type] => utility [patent_app_number] => 13/282755 [patent_app_country] => US [patent_app_date] => 2011-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18776 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13282755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7778695 [patent_doc_number] => 20120041061 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'USE OF PRODRUGS OF GABA ANALOGS FOR TREATING DISEASES' [patent_app_type] => utility [patent_app_number] => 13/283469 [patent_app_country] => US [patent_app_date] => 2011-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42227 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20120041061.pdf [firstpage_image] =>[orig_patent_app_number] => 13283469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7768087 [patent_doc_number] => 20120035209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'Hydroxy Substituted 1H-Imidazopyridines and Methods' [patent_app_type] => utility [patent_app_number] => 13/277619 [patent_app_country] => US [patent_app_date] => 2011-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32938 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20120035209.pdf [firstpage_image] =>[orig_patent_app_number] => 13277619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9094924 [patent_doc_number] => 20130274235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-17 [patent_title] => 'TREATMENT OF MOTOR NEURON DISEASE' [patent_app_type] => utility [patent_app_number] => 13/876177 [patent_app_country] => US [patent_app_date] => 2011-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10800 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13876177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7731456 [patent_doc_number] => 20120014917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'METHODS OF TREATING HIV PATIENTS WITH ANTI-FIBROTICS' [patent_app_type] => utility [patent_app_number] => 13/244752 [patent_app_country] => US [patent_app_date] => 2011-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 18758 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20120014917.pdf [firstpage_image] =>[orig_patent_app_number] => 13244752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7719815 [patent_doc_number] => 20120009150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'DIARYL UREAS FOR TREATING VIRUS INFECTIONS' [patent_app_type] => utility [patent_app_number] => 13/236865 [patent_app_country] => US [patent_app_date] => 2011-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31231 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20120009150.pdf [firstpage_image] =>[orig_patent_app_number] => 13236865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7720960 [patent_doc_number] => 20120010295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'Synergistic combinations comprising a renin inhibitor for cardiovascular diseases' [patent_app_type] => utility [patent_app_number] => 13/235787 [patent_app_country] => US [patent_app_date] => 2011-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8300 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20120010295.pdf [firstpage_image] =>[orig_patent_app_number] => 13235787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8928511 [patent_doc_number] => 20130184272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-18 [patent_title] => 'DIABETES THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 13/823915 [patent_app_country] => US [patent_app_date] => 2011-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26271 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13823915 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8892249 [patent_doc_number] => 20130165433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-27 [patent_title] => 'Novel Use' [patent_app_type] => utility [patent_app_number] => 13/821594 [patent_app_country] => US [patent_app_date] => 2011-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 96182 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13821594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8903637 [patent_doc_number] => 20130171141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-04 [patent_title] => 'COMBINATION OF HDAC INHIBITORS WITH THROMBOCYTOPENIA DRUGS' [patent_app_type] => utility [patent_app_number] => 13/819735 [patent_app_country] => US [patent_app_date] => 2011-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5194 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13819735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7791583 [patent_doc_number] => 20120053139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'METHOD FOR IMPROVING PHARMACOKINETICS OF PROTEASE INHIBITORS AND PROTEASE INHIBITOR PRECURSORS' [patent_app_type] => utility [patent_app_number] => 13/216743 [patent_app_country] => US [patent_app_date] => 2011-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 32936 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20120053139.pdf [firstpage_image] =>[orig_patent_app_number] => 13216743 [rel_patent_id] =>[rel_patent_doc_number] =>)